Therapeutic inhibition of Ang-2 and VEGF in mice intracardially injected with either melanoma or breast cancer cells, was associated with a substantial reduction of the metastatic brain tumor load by either AMG 386 or aflibercept administration alone or by dual anti-Ang-2/anti-VEGF therapy. This evidence concerns the gene ANGPT2 and breast carcinoma.